Sumitomo Mitsui Trust Group Inc. decreased its holdings in Quantum-Si Incorporated (NASDAQ:QSI – Free Report) by 10.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,690,720 shares of the company’s stock after selling 526,779 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 2.18% of Quantum-Si worth $5,160,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in QSI. Caitong International Asset Management Co. Ltd bought a new stake in Quantum-Si in the third quarter worth $84,000. Shay Capital LLC increased its holdings in shares of Quantum-Si by 19.2% in the third quarter. Shay Capital LLC now owns 154,572 shares of the company’s stock worth $218,000 after buying an additional 24,941 shares during the period. Bridgeway Capital Management LLC increased its holdings in shares of Quantum-Si by 33.1% in the third quarter. Bridgeway Capital Management LLC now owns 261,100 shares of the company’s stock worth $368,000 after buying an additional 65,000 shares during the period. Squarepoint Ops LLC bought a new stake in shares of Quantum-Si in the 3rd quarter valued at about $865,000. Finally, BNP Paribas Financial Markets lifted its stake in shares of Quantum-Si by 101.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 30,464 shares of the company’s stock valued at $43,000 after acquiring an additional 15,331 shares during the last quarter. Hedge funds and other institutional investors own 39.90% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on QSI shares. Canaccord Genuity Group dropped their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, March 4th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a research note on Friday, March 27th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $3.25.
Insider Transactions at Quantum-Si
In other Quantum-Si news, Director Paula Dowdy acquired 109,890 shares of the business’s stock in a transaction dated Thursday, March 5th. The shares were purchased at an average cost of $0.95 per share, for a total transaction of $104,395.50. Following the transaction, the director owned 269,107 shares in the company, valued at $255,651.65. This represents a 69.02% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Charles R. Kummeth bought 500,000 shares of Quantum-Si stock in a transaction dated Thursday, March 5th. The shares were acquired at an average cost of $0.92 per share, for a total transaction of $460,000.00. Following the completion of the purchase, the director directly owned 855,000 shares of the company’s stock, valued at approximately $786,600. This trade represents a 140.85% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have sold 54,429 shares of company stock worth $45,708. 22.04% of the stock is owned by company insiders.
Quantum-Si Stock Up 2.9%
Shares of Quantum-Si stock opened at $1.07 on Friday. The company’s fifty day simple moving average is $0.90 and its two-hundred day simple moving average is $1.29. Quantum-Si Incorporated has a 12-month low of $0.69 and a 12-month high of $3.10. The firm has a market cap of $231.52 million, a PE ratio of -2.06 and a beta of 3.08.
Quantum-Si (NASDAQ:QSI – Get Free Report) last issued its quarterly earnings data on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.06. The firm had revenue of $0.45 million during the quarter, compared to the consensus estimate of $0.76 million. Quantum-Si had a negative net margin of 4,160.06% and a negative return on equity of 43.90%. As a group, sell-side analysts expect that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.
Quantum-Si Profile
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Further Reading
Want to see what other hedge funds are holding QSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quantum-Si Incorporated (NASDAQ:QSI – Free Report).
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
